Form 4: Aspen Aerogels Director Cari Robinson Receives Stock and Option Grants

Director Cari Robinson received stock and option grants from Aspen Aerogels as part of the annual equity compensation for non-employee directors.

Summary

• On August 14, 2024, Cari Robinson, a director of Aspen Aerogels, received 1,876 shares of common stock and options to purchase 1,676 shares of common stock.
• The grants are part of the annual equity compensation for non-employee directors.
• The restricted shares and options will vest on the earlier of May 30, 2025, or the day prior to the company's 2025 annual meeting of stockholders.
• The option exercise price is $23.63 per share, and the options expire on August 14, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate governance practice of compensating directors with equity, which is generally viewed neutrally to positively.

Positives

• The equity grants align the director's interests with those of the shareholders.
• The vesting schedule encourages continued service on the board.

Industry Context

Equity compensation is a common practice for directors of publicly traded companies to align their interests with shareholders.

Comparison to Industry Standards

• Director compensation packages vary widely across industries and company sizes.
• Typically, director compensation includes a mix of cash retainers, meeting fees, and equity grants.
• Equity grants are often structured with vesting schedules to incentivize long-term commitment.

Stakeholder Impact

• The equity grants align the director's interests with those of the shareholders, potentially leading to better decision-making for the company's long-term success.

Key Dates